Palvella Therapeutics (PVLA) Q3 2025 Earnings

14AugConfirmed
Q4 2024
Q2 2025
Q3 2025
-4
-2.91
-1.83
-0.74

Details

Expected EPS
-0.740933
Actual EPS
-0.86
Surprise EPS
-0.12
Surprise Percent
+16.07%

Description

Palvella Therapeutics (PVLA) has reported earnings of -0.86 per share for Q3 2025.

0 Comments

Share your thoughts